Hims & Hers Health reported fourth-quarter results on Monday that beat analysts’ expectations, but the stock sank in extended trading.
Related Posts
China’s grueling ‘996’ work culture is being debated by European startups — 7 founders and VCs on why they are resisting
“What Europe really needs isn’t more hustle-porn it’s more aggressive funding,” Husmus’ co-founder Sarah Wernér told CNBC Make It on the work culture debate.
Amazon’s Ring launches AI-generated security alerts
The move is part of the smart home security company’s plans to push deeper into AI, Ring CEO Jamie Siminoff said.
Tesla investors are growing wary of Elon Musk’s futuristic promises
Tesla shares plummeted as CEO Elon Musk’s promises for robotaxis failed to excite investors following another disappointing earnings report.